Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Uterine Cervical Neoplasms 7Squamous Cell Carcinoma of Head and Neck 5Cholangiocarcinoma 5Carcinoma, Non-Small-Cell Lung 5Pancreatic Neoplasms 4Ovarian Neoplasms 4Gallbladder Neoplasms 3Neuroblastoma 2Neoplasm Metastasis 2Mesothelioma, Malignant 2Klatskin Tumor 2Ganglioneuroblastoma 2Fallopian Tube Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Triple Negative Breast Neoplasms 1Testicular Neoplasms 1Stomach Neoplasms 1Seminoma 1Sarcoma 1Recurrence 1Prostatic Neoplasms 1Pinealoma 1Peritoneal Neoplasms 1Penile Neoplasms 1Oropharyngeal Neoplasms 1Neuroendocrine Tumors 1

Interventions

Platinum 2Gemcitabine 2Cisplatin 21,2-diaminocyclohexaneplatinum II citrate 2ricolinostat 1fludarabine 1Specimen Handling 1N-Ac-CHAVC-NH2 1Magnetic Resonance Spectroscopy 1Cyclophosphamide 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Klatskin Tumor × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT01825603 2023-12-28

ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer

University of Nebraska

Phase 1 Completed
17 enrolled
Gastrointestinal

Gallbladder Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT02856568 2017-05-30

Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma

Mayo Clinic

Phase 1 Withdrawn
Gastrointestinal

Bile Duct Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡